Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2025-12-25 @ 12:27 AM
NCT ID:
NCT02509767
Eligibility Criteria:
Inclusion Criteria:
* Females ages 15-44
* Current or past users of DMPA or desires initiation of DMPA for contraception
* Can understand spoken and written English or Spanish
* Willing to consider/attempt DMPA self-injection
* Willing to be randomized to either self- or clinic administration of DMPA
* Do not want to become pregnant in the next 12 months
* Willing to provide contact information and to complete three surveys at baseline, 6 months, and 12 months
* Have consistent access to a working telephone, email, and Internet
* No contraindications to DMPA use
Exclusion Criteria:
* Suspected or confirmed pregnancy
* Vaginal bleeding of unknown etiology
* Known or suspected breast cancer
* Acute liver disease
* High blood pressure (Systolic ≥ 160 mm Hg or diastolic ≥ 100 mm Hg)
* Known hypersensitivity to medroxyprogesterone acetate or any other components of DMPA
* Desire for pregnancy within one year
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
15 Years
Maximum Age:
44 Years
Study:
NCT02509767
Study Brief:
Protocol Section:
NCT02509767